Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Hayes, Sandra C ^a   Rye, Sheree ^a   Battistutta, Diana ^a   DiSipio, Tracey ^a   Newman, Beth ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BREAST CANCER; CANCER SURVIVOR; CLINICAL ASSESSMENT; DISABILITY OF THE ARM, SHOULDER AND HAND QUESTIONNAIRE; DISABILITY OF THE ARM, SHOULDER AND HAND QUESTIONNAIRE BREAST QUESTIONNAIRE; FEMALE; HUMAN; LONG TERM CARE; LYMPH NODE; LYMPHEDEMA; MAJOR CLINICAL STUDY; MASTECTOMY; MORBIDITY; PHYSICAL PARAMETERS; POPULATION BASED CASE CONTROL STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT;

AUSTRALIA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHEDEMA; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; RANGE OF MOTION, ARTICULAR; RECOVERY OF FUNCTION; REPRODUCIBILITY OF RESULTS; SELF-ASSESSMENT; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; UPPER EXTREMITY;

EID: 77956469855     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-92     Document Type: Article

References (27)

1. Australian Institute of Health and Welfare and National Breast Cancer Centre Breast cancer in Australia: an overview. Canberra 2006, Australian Institute of Health and Welfare and National Breast Cancer Centre.
2. Satariano W, Ragland D, DeLorenze GN. Limitations in upper-body strength associated with breast cancer: A comparison of black and white women. J Clin Epidemiol 1996, 49:535-544. 10.1016/0895-4356(95)00565-X, 8636727.
3. Hladiuk M, Huchcroft S, Temple W, Schnurr BE. Arm function after axillary dissection for breast cancer: A pilot study to provide parameter estimates. J Surg Oncol 1992, 50:47-52. 10.1002/jso.2930500114, 1573894.
4. Keramopoulos A, Tsionou C, Minaretzis D, Michalas S. Arm morbidity following treatment of breast cancer with total axillary dissection: A multivariated approach. Oncology 1993, 50:445-449. 10.1159/000227227, 8233285.
5. Lilijegren G, Holmberg L, . Uppsala Orebro Breast Cancer Study Group Arm morbidity after section resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Eur J Cancer 1997, 33:193-199. 10.1016/S0959-8049(96)00375-9, 9135487, Uppsala Orebro Breast Cancer Study Group.
6. Rietman JS, Kijkstra PU, Geertzen JHB, Baas P, de Vries J, Dolsma WV, Groothoff JW, Eisma WH, Hoekstra HJ. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 2004, 11:1018-1024. 10.1245/ASO.2004.03.512, 15525832.
7. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000, 88:608-614. 10.1002/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K, 10649254.
8. Gosselink R, Rouffaer L, Vanhelden P, Piot W, Troosters T, Christiaens M. Recovery of upper limb function after axillary dissection. J Surg Oncol 2003, 83:204-211. 10.1002/jso.10271, 12884231.
9. Haid A, Koberle-Wuhrer R, Knauer M, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, Zimmerman G. Morbidity of breast cancer patients following complete axillar dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 2002, 73:31-36. 10.1023/A:1015234318582, 12083629.
10. Leidenius M, Leppanen E, Krogerus L, Von Smitten K. Motion restriction and axillary web syndrom after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 2003, 185:127-130. 10.1016/S0002-9610(02)01214-X, 12559441.
11. Peintinger F, Reitsamer R, Stranzi H, Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 2003, 89:648-652. 10.1038/sj.bjc.6601150, 2376906, 12915872.
12. Rietman JS, Dijkstra PU, Debreczeni R, Geertzen JHB, Robinson DPH, de Vries J. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil 2004, 26:78-84. 10.1080/09638280310001629642, 14668143.
13. Ernst MF, Voogd AC, Balder W, Klinkenbijl JHG, Roukema JA. Early and late morbidity associated with axillary levels I-III dissection in breast cancer. J Surg Oncol 2002, 79:151-155. 10.1002/jso.10061, 11870664.
14. Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Maiterth S, Dahlbender R, Wendt I, Kreienberg R. Long-term morbidity following axillary dissection in breast cancer patients - clinical assessment, significance for quality of life and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 2000, 64:275-286. 10.1023/A:1026564723698, 11200778.
15. Hayes S, Battistutta D, Newman B. Objective and subjective upper-body function six months following diagnosis of breast cancer. Breast Cancer Res Treat 2005, 94:1-10. 10.1007/s10549-005-5991-z, 16172793.
16. Rietman JS, Kijkstra PU, Hoekstra HJ, Eisma WH, Szabo BG, Groothoff JW, Geertzen JHB. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol 2003, 29:229-238. 10.1053/ejso.2002.1403, 12657232.
17. Karki A, Simonen R, Malkia E, Selfe J. Impairments, activity limitations and participation restrictions 6 and 12 months after breast cancer operation. J Rehabil Med 2005, 37:180-188.
18. Kwan W, Jackson J, Weir LM, Dingee C, McGregor G, Olivotto IA. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 2002, 20:4242-4248. 10.1200/JCO.2002.09.018, 12377968.
19. Engel J, Kerr J, Schlesigner-Raab A, Eckel R, Sauer H, Holzel D. Predictors of quality of life of breast cancer patients. Acta Oncol 2003, 42:710-718. 10.1080/02841860310017658, 14690156.
20. Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 2008, 26:1355-1363. 10.1200/JCO.2007.13.3439, 18227528.
21. Hayes SC, Janda M, Cornish B, Battistutta D, Newman B. Lymphoedema following breast cancer: incidence, risk factors and effect on upper body function. J Clin Oncol 2008, 26:3536-3542. 10.1200/JCO.2007.14.4899, 18640935.
22. Solway S, Beaton D, McConnell S, Bombardier C. The DASH Outcome Measure User's Manual, Second Edition 2002, Toronto: Institute for Work and Health, 2.
23. Brady M, Cella D, Mo F, Bonomi A, Tulsky D, Lloyd S, Deasy S, Cobleight M, Shiomoto G. Reliability and validity of the Functional Assessment of Cancer Therapy - Breast (FACT-B) quality of life instrument. J Clin Oncol 1997, 15:974-986.
24. Di Sipio T, Hayes S, Janda M, Newman B. What determines the health-related quality of life among regional and rural breast cancer survivors. Aust N Z J Public Health 2009, 33(6):534-539. 10.1111/j.1753-6405.2009.00449.x, 20078570.
25. Di Sipio T, Hayes S, Battistutta D, Janda M, Newman B. Patterns, correlates, and prognostic significance of quality of life following breast cancer. Psycho-Oncology
26. Ververs JM, Roumen RM, Vingerhoets AJ, Vreugdenhil G, Coebergh JWW, Crommelin MA, Luiten EJT, Repelaer van Driel OJ, Schijven M, Wissing JC, Voogd AC. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 2001, 37:991-999. 10.1016/S0959-8049(01)00067-3, 11334724.
27. Hayes S, Spence R, Galvao D, Newton R. Australian Association for Exercise and Sport Science Position Stand: Optimising cancer outcomes through exercise. J Sci Med Sport 2009, 12:428-434. 10.1016/j.jsams.2009.03.002, 19428291.